Evopoint Biosciences Co., Ltd. (SHA:688837)

Market Cap	21.51B
Revenue (ttm)	1.11B
Net Income	408.51M
EPS	1.11
Shares Out	435.49M
PE Ratio	44.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,122,105
Open	43.20
Previous Close	43.61
Day's Range	43.20 - 50.33
52-Week Range	39.12 - 78.98
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Evopoint Biosciences

Evopoint Biosciences Co., Ltd. operates as a biopharmaceutical company that offers therapies for patients with oncology and multidrug-resistant (MDR) infections in China. It offers its three-core technology platforms, Small Molecule Drug Discovery Platform that uses multi-omics, functional screening, and a medicinal chemistry engine to create precision therapies for epigenetics, synthetic lethality, and MDR infections; Novel Antibody Discovery Platform which offers antibody therapeutics (e.g., ADCs, bispecifics, TCEs) to achieve precision and e...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2017
• Employees: 362
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688837

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error